This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Day One Biopharmaceuticals, Inc. The single-award BPA has a ceiling value of $15,000,000.00 and a period of performance ending on March 7, 2026. The BPA is for the procurement of OJEMDA, though the specific products and services to be delivered are not explicitly stated in the provided information. As a BPA, this contract vehicle allows the agency to place orders for recurring products and services from the prime contractor, Day One Biopharmaceuticals, Inc., without the need to re-compete each individual purchase. The BPA was awarded on March 8, 2025 and does not utilize any set-asides.
Generated 3/8/25, 9:47 AM